Literature DB >> 18572139

Drug-eluting particles for interventional pharmacology.

Eleni Liapi1, Kwang-Hun Lee, Christos C Georgiades, Kelvin Hong, Jean-Francois H Geschwind.   

Abstract

Chemoembolization with drug-eluting particles has been recently introduced in the field of interventional oncology. In this review, we will describe the pharmacokinetic properties and efficacy of all commercially available or under investigation drug-eluting particles and discuss the potentials and future of this new form of transcatheter arterial therapy for liver cancer.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18572139     DOI： 10.1053/j.tvir.2008.03.003

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN： 1557-9808


  13 in total

1.  Surgical and Locoregional Therapy of HCC: TACE.

Authors:  Masakatsu Tsurusaki; Takamichi Murakami
Journal:  Liver Cancer       Date:  2015-07-10       Impact factor: 11.740

Review 2.  Non-operative therapies for colorectal liver metastases.

Authors:  John L Nosher; Inaya Ahmed; Akshar N Patel; Vyacheslav Gendel; Philip G Murillo; Rebecca Moss; Salma K Jabbour
Journal:  J Gastrointest Oncol       Date:  2015-04

Review 3.  Bench-to-clinic development of imageable drug-eluting embolization beads: finding the balance.

Authors:  Andrew L Lewis; Sean L Willis; Matthew R Dreher; Yiqing Tang; Koorosh Ashrafi; Bradford J Wood; Elliot B Levy; Karun V Sharma; Ayele H Negussie; Andrew S Mikhail
Journal:  Future Oncol       Date:  2018-06-26       Impact factor: 3.404

4.  Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement.

Authors:  Roderich E Schwarz; Ghassan K Abou-Alfa; Jeffrey F Geschwind; Sunil Krishnan; Riad Salem; Alan P Venook
Journal:  HPB (Oxford)       Date:  2010-06       Impact factor: 3.647

Review 5.  Current status of embolic agents for liver tumor embolization.

Authors:  Keigo Osuga; Noboru Maeda; Hiroki Higashihara; Shinichi Hori; Tetsuro Nakazawa; Kaishu Tanaka; Masahisa Nakamura; Kentaro Kishimoto; Yusuke Ono; Noriyuki Tomiyama
Journal:  Int J Clin Oncol       Date:  2012-07-18       Impact factor: 3.402

6.  Chemoembolization of liver cancer with doxorubicin-loaded CalliSpheres microspheres: plasma pharmacokinetics, intratumoral drug concentration, and tumor necrosis in a rabbit model.

Authors:  Bin Liang; Dan Zhao; Yiming Liu; Xiaopeng Guo; Hongsen Zhang; Lijie Zhang; Chuansheng Zheng
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

7.  Preparation and characterization of ketoprofen-loaded microspheres for embolization.

Authors:  Chao Zhou; Daichao Cui; Yuan Zhang; Huiyan Yuan; Tianyuan Fan
Journal:  J Mater Sci Mater Med       Date:  2011-11-22       Impact factor: 3.896

Review 8.  Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?

Authors:  Eleni Liapi; Jean-Francois H Geschwind
Journal:  Cardiovasc Intervent Radiol       Date:  2010-11-12       Impact factor: 2.740

9.  Transcatheter intra-arterial infusion of doxorubicin loaded porous magnetic nano-clusters with iodinated oil for the treatment of liver cancer.

Authors:  Min Jeong Jeon; Andrew C Gordon; Andrew C Larson; Jin Wook Chung; Young Il Kim; Dong-Hyun Kim
Journal:  Biomaterials       Date:  2016-02-18       Impact factor: 12.479

10.  Poly(lactide-co-glycolide) microspheres for MRI-monitored transcatheter delivery of sorafenib to liver tumors.

Authors:  Jeane Chen; Alexander Y Sheu; Weiguo Li; Zhuoli Zhang; Dong-Hyun Kim; Robert J Lewandowski; Reed A Omary; Lonnie D Shea; Andrew C Larson
Journal:  J Control Release       Date:  2014-04-13       Impact factor: 9.776
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.